OGCT-07 ICON-RT: A RANDOMIZED PHASE 2 TRIAL OF CONSOLIDATIVE STEREOTACTIC RADIOSURGERY (SRS) VERSUS CONTINUED OSIMERTINIB IN EGFR-MUTANT NSCLC PATIENTS WITH RESIDUAL BRAIN METASTASES FOLLOWING INITIAL TKI RESPONSE
Authors
Helena A. Yu (ORCID: https://orcid.org/0000-0002-0377-9510)
Mark Jeng (ORCID: https://orcid.org/0000-0003-0854-761X)
E. Berglin W-O (ORCID: https://orcid.org/0009-0008-2337-5856)
Ahmed R. Rezk (ORCID: https://orcid.org/0000-0002-6591-9734)
Sohrab P. Shah (ORCID: https://orcid.org/0000-0001-6402-523X)
Luke Pike (ORCID: https://orcid.org/0000-0001-9622-7442)
Jake J. Lee (ORCID: https://orcid.org/0000-0002-8175-9486)
OGCT-07 ICON-RT: A RANDOMIZED PHASE 2 TRIAL OF CONSOLIDATIVE STEREOTACTIC RADIOSURGERY (SRS) VERSUS CONTINUED OSIMERTINIB IN EGFR-MUTANT NSCLC PATIENTS WITH RESIDUAL BRAIN METASTASES FOLLOWING INITIAL TKI RESPONSE
Helena A. Yu, Mark Jeng, E. Berglin W-O, Ahmed R. Rezk et al.
Journal
Neuro-Oncology Advances
Topics
Lung Cancer Treatments and Mutations
article
OGCT-07 ICON-RT: A RANDOMIZED PHASE 2 TRIAL OF CONSOLIDATIVE STEREOTACTIC RADIOSURGERY (SRS) VERSUS CONTINUED OSIMERTINIB IN EGFR-MUTANT NSCLC PATIENTS WITH RESIDUAL BRAIN METASTASES FOLLOWING INITIAL TKI RESPONSE
Helena A. Yu, Mark Jeng, E. Berglin W-O, Ahmed R. Rezk, Sohrab P. Shah, Luke Pike, Jake J. Lee, Emily Miao, Marc Williams, Michael Valerie
article en
Abstract
No abstract available for this paper.
Publication Tag
Neuro-Oncology AdvancesVol. 7(Supplement_2)
Institutions
Memorial Sloan Kettering Cancer Center (US), Tanta University (EG)